Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT02364102
Eligibility Criteria:
Inclusion Criteria:
* informed consent
* Serum thyroid-stimulating hormone (TSH) \> 4.5 milli-International unit (mIU)/l
* body mass index (weight/height(m)²) 17.5 to 30 kg/m²
Exclusion Criteria:
* known concomitant disease influencing thyroid hormone metabolism
* chronic heart failure
* liver cirrhosis
* severe kidney failure
* metastasized cancer, except for thyroid cancer
* known hypersensitivity to cold, e.g. primary or secondary Raynaud's syndrome
* abuse of alcohol or illicit drugs
* Women who are pregnant or breast feeding
* Intention to become pregnant during the course of the study
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
* Participation in another study with investigational drug within the 30 days preceding and during the present study
* Previous enrolment into the current study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02364102
Study Brief:
Protocol Section:
NCT02364102